Biotechnology Pharmaceuticals

Statistics · 2026

Microalgae Industry Statistics

Global aquaculture hit 82.1 million tonnes in 2018—and microalgae-based feeds are a key demand driver. Explore the microalgae industry stats behind it.

Statistics · 2026

Biopharmaceutical Industry Statistics

Phase III trials cost about $255M per drug on average in 2023—see what drives the industry’s investment pipeline.

Statistics · 2026

Opiod Statistics

In 2021, synthetic opioids (mostly fentanyl) were in 88% of 71,238 opioid-involved deaths—see how the crisis is shifting.

Statistics · 2026

Turkey Pharmaceutical Industry Statistics

Turkey’s pharma exports reached $1.82B in 2023 (+22%). Generic drugs were $1.1B—explore what’s driving the surge.

Statistics · 2026

Biopharma Industry Statistics

Gene therapy is forecast to grow to $250.0B by 2023—plus 17% of biopharma trials are adding decentralization. See the numbers.

Statistics · 2026

Bio Industry Statistics

Bioeconomy market size reached $307.3B in 2022—while biopharma funding fell 11% YoY in 2023. Explore the signals shaping bio industry investment.

Statistics · 2026

Hydrocodone Statistics

10.1 million U.S. residents aged 12+ misused prescription pain relievers in the past year—hydrocodone is among the opioids involved.

Statistics · 2026

Bio Healthcare Industry Statistics

Oncology trials drove 38% of biotech’s 2023 studies—explore the Bio Healthcare Industry stats behind what’s moving fastest.

Statistics · 2026

Vaccine Industry Statistics

13.5B+ COVID-19 vaccine doses were administered worldwide by end-2022—yet 3.2B children missed at least one routine dose. Explore the gap.

Statistics · 2026

Insulin Statistics

WHO estimates 422 million adults worldwide lived with diabetes in 2014—discover why insulin can be essential for type 1 care.

Statistics · 2026

Weight Loss Drugs Food Industry Statistics

U.S. obesity drug prescriptions surged in 2023—see how that demand is reshaping what Americans buy and how food rules respond.

Statistics · 2026

Life Sciences Industry Statistics

Global patent filings hit 250,000 in 2023—discover what this surge signals for innovation, funding, and therapies.

Statistics · 2026

Korea Bio Industry Statistics

Biopharmaceutical exports hit USD 8.7B in 2023 (61% of total)—see what’s driving Korea’s biotech trade momentum and pipeline.

Statistics · 2026

Biotechnology Healthcare Industry Statistics

U.S. biotech VC funding hit USD 35B in 2023—down 30% from the 2022 peak. Explore what’s fueling the next approvals.

Statistics · 2026

Korean Pharmaceutical Industry Statistics

South Korea’s pharma exports reached $12.8 billion in 2023—see how biotech, generics, and key destinations power the figures.

Statistics · 2026

Indian Pharma Industry Statistics

Exports grew 8.5% YoY to $25.39B in FY23—India’s pharma is scaling fast. Explore jobs, R&D, and capacity signals behind the surge.

Statistics · 2026

Us Biotechnology Industry Statistics

US biotechs generated $50B in mRNA vaccine sales in 2022—see the growth metrics, jobs, and funding behind the surge.

Statistics · 2026

Genomics Industry Statistics

Statistics · 2026

Bioinformatics Statistics

With genomics data set to hit 2,800 petabytes by 2030, the page connects research and operational reality to why bioinformatics statistics matter, from 5.5 billion annual U.S. clinical data points from genomic tests to 52% of labs already running cloud workloads. You also get the operational tension behind pipeline design and reuse, including 43% of organizations struggling with cross system integration and workflow practices like Nextflow style reproducible DAG execution that increasingly separate results that can be trusted from those that cannot.

Statistics · 2026

Biotech Pharma Industry Statistics

Biotech and biopharma are accelerating fast as the global biotechnology market is projected to hit $1.26 trillion by 2030 and CDMO growth is forecast at 4.1% annually through 2032. At the same time, investors put $91.0 billion into biotech in 2021 and the FDA keeps tilting approvals toward biologics, making these supply chain and regulatory signals impossible to ignore for anyone tracking what is next in drug development.